News >

Immunotherapy Makes Waves in Small Cell Lung Cancer

Jessica Hergert
Published: Thursday, Feb 27, 2020

Alain C. Mita, MD, an associate professor of medicine and co-director of Experimental Therapeutics at Cedars-Sinai Medical Center

Alain C. Mita, MD

Until recently, the treatment armamentarium for extensive-stage small cell lung cancer (ES-SCLC) did not have significant advances, said Alain C. Mita, MD. In the last 2 years, however, the arrival of multiple immune checkpoint inhibitors has expanded the treatment paradigm in both the frontline and recurrent settings for this patient population.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication